On March 25th, Egypt's state-owned Eastern Company announced a 2-3 Egyptian pound (equivalent to approximately 0.44-0.66 yuan) increase in the average price of each pack of cigarettes, cigars, and pipe tobacco.
Ten packs of Cleopatra cigarettes are currently selling for 15 Egyptian pounds (about 3.3 yuan), while a pack of Cleopatra King Size is priced at 23 Egyptian pounds (about 5 yuan). Viceroy and Pall Mall cigarettes are selling for 33 Egyptian pounds (about 7.3 yuan) per pack.
The prices of Cleopatra Soft Queen, Boston/Belmont, Cleopatra Box (in white, black, and color), Cleopatra Mondial Switch, and Matossian cigarettes have all increased to 24 Egyptian pounds (approximately 5 yuan) per pack.
This is the first price increase for the company in 2023, following two previous increases in September 2022 and March 2022.
According to reports, the state-owned Eastern Tobacco Company of Egypt was established in 1920 and is the largest tobacco producer in Egypt.
The revenue of Eastern Company increased by 6% in 2022, reaching 67.9 billion Egyptian pounds (approximately 15.1 billion Chinese yuan), higher than the 63.8 billion Egyptian pounds (approximately 4.2 billion Chinese yuan) of the fiscal year 2021.
In September of last year, a subsidiary of Philippine-based company PMI partnered with tobacco company UTC to begin producing cigarettes in the Egyptian market. This marked the end of decades-long monopoly on cigarette production by a single company.
Reference:
Local cigarette prices in Egypt have increased by EGP 2-3 per pack.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
